US equities |
MU $1,062.47 ▲+1.62% SNDK $1,705.00 ▲+2.68% NVDA $237.16 ▼-0.87% AMD $642.21 ▼-1.11% INTC $113.58 ▲+0.96% SPCX $167.84 ▼-2.37% TSLA $375.37 ▼-1.39% MRVL $281.11 ▼-2.06%
FinancialContent

Articles published by CSL Behring

News headline image
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
From CSL Behring
Via GlobeNewswire
Tickers ASX CSLLY